Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 211-522-5 | CAS number: 657-84-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 995
- Report date:
- 1995
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- Buehler test
- Justification for non-LLNA method:
- The in vivo study data were obtained in studies performed before any in vitro sensitization tests tests had been validated and accepted for regulatory purposes.
Test material
- Reference substance name:
- Sodium toluene-4-sulphonate
- EC Number:
- 211-522-5
- EC Name:
- Sodium toluene-4-sulphonate
- Cas Number:
- 657-84-1
- Molecular formula:
- C7H7O3S.Na
- IUPAC Name:
- 4-methylbenzenesulfonic acid
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- other: Dunkin Hartley, Pirbright White
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS- Source: Harlan Winkelmann GmbH, Versuchstierzucht, Borchen, Germany- Age at study initiation: young adults, no further details mentioned- Weight at study initiation: 317 ± 21 g- Housing: conventional, Makrolon Type IV cages (maximum 5 animals per cage) - Diet (e.g. ad libitum): Ssniff G4 complete feed for guinea pigs ad libitum, supplied by Ssniff Spezialfutter GmbH, Soest, Germany- Water (e.g. ad libitum): drinking water ad libitum, supplied by Gelsenwasser, Wasserwerk, Haltern, Germany- Acclimation period: at least 5 daysENVIRONMENTAL CONDITIONS- Temperature (°C): 22 ± 3- Humidity (%): 30 - 70- Air changes (per hr): 15 - Photoperiod (hrs dark / hrs light): 12/12IN-LIFE DATES: From: 1995-03-06 To: 1995-03-09 (preliminary study) From: 1995-03-20 To: 1995-04-20 (main study)
Study design: in vivo (non-LLNA)
Induction
- Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- induction: 42.79 % (delivery form)challenge: 42.79 % (delivery form)
Challenge
- Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- induction: 42.79 % (delivery form)challenge: 42.79 % (delivery form)
- No. of animals per dose:
- test animals: 20 (main experiment), 3 (pilot study), 3 (determination of challenge concentration) control animals: 10
- Details on study design:
- RANGE FINDING TESTS: Determination of the non-irritant concentration of the test substance with occlusive epicutaneous applications for 6 hours of test substance 5%, 10%, 20% in deionized water and 42.79% (delivery form). Reading at 30 and 54 hours after application. Redetermination of the maximum non-irritant concentration for the challenge treatment in the 4th week with 3 additional guinea pigs which had not been treated up to this time. The concentrations and test conditions were the same as in the pilot study. This additional testing was carried out because it was suspected that the sensitivity of the skin changed as the weight of the animals increased. This ensured that the challenge concentration was determined on animals which had approx. the same weights as the 30 animals in the challenge phase.
MAIN STUDY
A. INDUCTION EXPOSURE- No. of exposures: 3- Exposure period: occlusive dermal applications for 6 hours, scoring at 30 hours after start of application- Test group: receiving test substance (0.3 cm³/patch)- Control group: receiving vehicle (0.3 cm³/patch)- Site: left flanks- Frequency of applications: induction on days 0, 7 and 14- Duration: 3 weeks- Concentrations: 42.79% (delivery form)
B. CHALLENGE EXPOSURE- No. of exposures: 1- Day(s) of challenge: on day 28- Exposure period: occlusive dermal application for 6 hours- Test groups: receiving test substance solution and vehicle (0.3 cm³/patch each)- Control group: receiving test substance solution and vehicle (0.3 cm³/patch each)- Site: right flanks (front: vehicle, back: test substance solution)- Concentrations: 42.79% (delivery form)- Evaluation (hr after challenge): 24 and 48 hours - Challenge controls:
- same treatment as test group animals
- Positive control substance(s):
- yes
- Remarks:
- 2-Mercaptobenzothiazole
Results and discussion
- Positive control results:
- The sensitivity of the used guinea pig strain was checked from 1994-11-07 to 1994-12-02. The test compound was used as an well-known standard allergen. The maximisations method was carried out for this test. A test goup of 10 and a control group of 5 animals were used to test the sensitivity. 48 and 72 hours after challenge treatment all skin reaction were recorded: Dermal irritation was found on the right flank of 9 of 10 test animals 48 and 72 hours after treatment with the allergen. Treatment of the test animals with the vehicle on the left flank likewise resulted in a slight or to distinct subcutaneous reaction after 48 and 72 hours in two animals.There were no signs of irritation at these times on the skin on the left (standard allergen) and right (vehicle) flanks of the control animals.It was necessary to pretreat the skin with 10% sodium dodecylsulphate in vaseline in order to cause slight to moderate cutaneous inflammation, because the highest allergen concentration which could be administered satisfactorily caused no dermal irritation.On the basis of these results (90% of test animals showed evidence of delayed contact hypersensitivity), the guinea pig strain was judged to be sensitive under the test conditions described. In the maximisation method, a figure of 30% or more is regarded as positive result.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 42.79%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- no clinical effects observed
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 42.79%. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: no clinical effects observed.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 42.79%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- no clinical effects observed
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 42.79%. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: no clinical effects observed.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 42.79%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- no clinical effects observed
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 42.79%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: no clinical effects observed.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 42.79%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- no clinical effects observed
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 42.79%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: no clinical effects observed.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Remarks on result:
- positive indication of skin sensitisation
Any other information on results incl. tables
RESULTS OF PILOT STUDY
No irritant effects at any concentration of the test substance tested.
RESULTS OF TEST
- Sensitisation reaction: No sensitising effects observed.
- Clinical signs: No clinical effects observed. Body weight increase comparable to control.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Not skin sensitizer
- Executive summary:
The skin sensitization potential of Sodium toluene 4-sulphonate was assessed following official guideline OECD 406, Skin sensitization. In this test Guinea pigs are treated by intradermal injection in the shoulder region to induce sensitization and 7 days later the sensitizationis boosted by an occluded patch placed over the injection site. 14 days later the animals are challengedon the flank by occluded patch. There action site is examined 24 hours and 48 hours after removal of the patch. No animals showed a challenge reaction at 24 or 48 hours, therefore the tested substance is considered to be non skin sensitizer.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.